ENVB Earnings — Enveric Biosciences, Inc. Common Stock Post-ER Performance | BigEarnings
ENVB — Enveric Biosciences, Inc. Common Stock
XNAS
Price$2.30
Market Cap$8.5M
P/E—
52W Range$1.71 – $17.64
Next Earnings2026-08-13
About Enveric Biosciences, Inc. Common Stock
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
